Introduction
============

The increase in the aging population has led to a rise in the incidence of osteoarthritis (OA), which is accompanied by a high economic burden on the whole society. OA is the most common type of degenerative arthritis among individuals from different countries; also, since it progresses slowly, it is not detected and diagnosed at the early stage, causing a delay of treatment and a limitation of its efficacy ([@b1-etm-0-0-7897]). OA frequently occurs in active joints, including the knee and hip. According to epidemiological studies, the incidence of individuals \>55 years of age suffering from OA is 44--70%, and 10% of patients experience pain in the joints, along with reduced muscle strength and decline in joint stability and mobility, which in turn results in walking difficulties and severely affects daily life ([@b2-etm-0-0-7897]--[@b4-etm-0-0-7897]). Typically, OA affects large weight-bearing joints, particularly the knees, where the disease is disabling, as the knees participate in several basic activities, including standing up from a seated position, climbing, walking and running ([@b5-etm-0-0-7897]). Knee OA (KOA) has various clinical symptoms, including pain associated with muscles and tendons, which may decrease the range of motion, crepitus with movement and joint effusion in the knee. Reportedly, the incidence of KOA among individuals \>60 years of age is 50% and that of individuals aged \>75 years is \~80% ([@b6-etm-0-0-7897]).

In recent years, there has been a growing interest in shockwave treatment for orthopedic diseases, including KOA. Several musculoskeletal diseases have been treated with shockwave therapy ([@b7-etm-0-0-7897]). The effect of the therapy includes pain relief, improvement of joint movement and prevention of the progression of avascular necrosis ([@b8-etm-0-0-7897],[@b9-etm-0-0-7897]). Shockwave treatment has several advantages, including non-invasiveness, low complication rate, no hospitalization and low cost as compared to other approaches. Accordingly, shockwave treatment is beneficial at the specific stage when surgery was selected as the approach for several associated diseases ([@b10-etm-0-0-7897],[@b11-etm-0-0-7897]). Extracorporeal shockwave therapy (ESWT) has been increasingly used in patients suffering from KOA ([@b12-etm-0-0-7897]--[@b14-etm-0-0-7897]), and in clinical trials, ESWT was compared with physical therapy or placebo. The outcome indicators included visual analog scale (VAS) score, range of motion (ROM), Lequesne index (LI) and Western Ontario and McMaster Universities osteoarthritis index (WOMAC). A majority of the studies indicated that ESWT offered better pain relief than placebo. Conversely, the study by Imamura *et al* ([@b15-etm-0-0-7897]) did not demonstrate any statistically significant difference between ESWT and placebo treatment in pain control on patients with severe KOA and disabling pain. In addition, the results regarding other outcome measures were different among various studies. Thus, the present meta-analysis was performed to ascertain whether ESWT is superior to physical or placebo therapy with regard to all outcome indicators.

Materials and methods
=====================

### Search strategy

The present meta-analysis was in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for the meta-analysis of intervention trials ([@b16-etm-0-0-7897]).

The PubMed, Medline, Embase, Web of Science, Research Gate and the Cochrane Library were searched for comparative studies involving ESWT for patients with KOA published until February 2019. The search terms were as follows: 'Extracorporeal shockwave therapy' OR 'physical therapy' OR 'exercise therapy' AND 'osteoarthritis' OR 'knee osteoarthritis' OR 'knee arthritis'. The language of the publications was limited to English. The title and abstract of the studies identified in the search were reviewed to exclude irrelevant studies. The reference lists of all eligible studies and relevant reviews were searched manually for additional trials.

### Inclusion criteria and study selection

First, the studies comparing ESWT to physical therapy or ESWT to placebo in patients suffering from KOA were identified. The primary outcomes included the pain score and ROM, while the secondary outcomes were the LI and WOMAC. Subsequently, studies comparing ESWT and physical therapy in patients with KOA were selected, in which the primary outcomes included the pain score and ROM, while the secondary outcome was the WOMAC. Studies that reported on at least one outcome measure were included, and those without the outcome measures of interest were excluded. Furthermore, studies that did not contain data that could be used for analysis were excluded. Letters, comments, editorials and practice guidelines were also excluded.

### Data extraction and quality assessment

The authors read all titles and abstracts that were identified according to the eligibility criteria. The articles meeting the inclusion criteria were reviewed in further detail. Further discussion amongst the listed authors settled any differences in order to reach a consensus. The authors used standardized tables to extract data on patient characteristics (age, sex, and so on), interventions, and outcomes in duplicate. Other formats data \[i.e., median, interquartile range\] were converted to mean ± standard deviation according to the Cochrane Handbook ([@b17-etm-0-0-7897]). If there was no report in digital format then data was extracted from the figures published by manual measurement. If necessary, we contacted the corresponding author to confirm the information fulfilled the criteria described above.

The risk of bias in each study was assessed. We evaluated the rigor of the randomized process, the concealment of treatment allocations, the process of blinding, data integrity and the results according the Cochrane Collaboration Recommendations ([@b17-etm-0-0-7897]). For the purpose of this meta-analysis, randomization, concealment of treatment allocation, and blinding and integrity were identified as key areas to determine the risk of bias. In each study included, the risk of bias was determined to be low when all key areas were fully assessed. When one or more key areas are not clearly described, the risk of bias is identified as unclear. When one or more key areas are inadequate, the risk of bias is determined to be high. The quality of evidence for each outcome was determined by considering the risk of bias. The assessment of the risk of bias is shown in [Fig. 1](#f1-etm-0-0-7897){ref-type="fig"}.

All calculations were made using the mean difference (MD) with a 95% CI that was calculated for continuous data using RevMan v5.3 ([@b16-etm-0-0-7897]). The heterogeneity among studies was estimated using I^2^ statistics and substantial heterogeneity was considered if I^2^\>50%. The random-effects model was adopted for the meta-analysis of all data. Because the random effect model could be used in all cases, if the heterogeneity was small, then there would be no large difference between random effect model and fixed effect model. When the heterogeneity is large, only the random effect model could be used therefore the random effect model was used in all cases. P\<0.05 was considered to indicate statistical significance. Sensitivity analysis explored the impact of individual studies by removing one study at a time in sequence.

Results
=======

### Search results

Initially, a total of 127 studies were retrieved, among which 47 were identified as duplicates and were excluded. The titles and abstracts of the remaining studies were read and 20 studies that did not fulfill the inclusion criteria were excluded. Subsequently, 24 articles that were not randomized controlled trials (RCTs) were also excluded ([Fig. 2](#f2-etm-0-0-7897){ref-type="fig"}). Finally, seven studies comprising 366 patients were included for data extraction and meta-analysis. Of these, 169 patients were in the ESWT group ([@b15-etm-0-0-7897],[@b18-etm-0-0-7897]--[@b23-etm-0-0-7897]) and 140 in the placebo group ([@b15-etm-0-0-7897],[@b18-etm-0-0-7897]--[@b21-etm-0-0-7897]) and 57 patients belonged to the physical therapy group ([@b18-etm-0-0-7897],[@b22-etm-0-0-7897],[@b23-etm-0-0-7897]).

### Study characteristics and quality assessment

The eligible studies included were published between 2013 and 2017. All of the studies were RCTs. The subjects in the two groups had similar demographic data. All trials used ESWT, except for the study by Imamura *et al* ([@b15-etm-0-0-7897]), which used radial ESWT. This may have led to heterogeneity in data analysis. In the ESWT group, all patients underwent treatment at least once per week and the total number of sessions exceeded 3 times. In the placebo group, the patients received the same number of impulses of sham stimulation with an energy of 0 on the same area so that they did not realize they were not treated. In the physical therapy group, participants performed various exercises, including stretching, global flexion-extension of the lower limb and strengthening. However, not all studies assessed the same indicators. In the present meta-analysis, the outcomes of muscle peak torques and the modified Barthel index were not analyzed owing to insufficient data.

### Meta-analysis of ESWT vs. placebo

A total of four studies ([@b15-etm-0-0-7897],[@b18-etm-0-0-7897]--[@b20-etm-0-0-7897]) involving 218 patients reported on the VAS score around 4 weeks following completion of therapy. The statistical heterogeneity between the studies was high as evaluated by a random-effects model (P=0.06, I^2^=59%; [Fig. 3](#f3-etm-0-0-7897){ref-type="fig"}). However, after the fourth study was removed, the statistical heterogeneity of the remaining three studies was significantly reduced (P=0.33, I^2^=9%; [Fig. 4](#f4-etm-0-0-7897){ref-type="fig"}). Meta-analysis of the data revealed that the VAS scores of ESTW patients were significantly lower than those in the placebo-treated patients after therapy after 1 month (MD=−2.35, 95% CI: −2.92 to −1.79, P\<0.00001).

A total of two studies ([@b18-etm-0-0-7897],[@b20-etm-0-0-7897]) including 95 patients reported on the ROM of knees after therapy for 1 month. The statistical heterogeneity between the studies was low as assessed by a random-effects model (P=0.20, I^2^=38%). The increase in the ROM scores in the ESWT group was significantly higher than that in the placebo group after treatment (MD=17.58, 95% CI: 12.88--22.28, P\<0.00001; [Fig. 5](#f5-etm-0-0-7897){ref-type="fig"}).

The LI after treatment for 1 month was assessed by two studies ([@b18-etm-0-0-7897],[@b21-etm-0-0-7897]) comprising 116 patients. The statistical heterogeneity between the studies was reliable, as assessed by a random-effects model (P=0.27, I^2^=18%). The ESWT group scored significantly lower than the placebo group (MD=−3.06, 95% CI: −3.90 to −2.21, P\<0.00001; [Fig. 6](#f6-etm-0-0-7897){ref-type="fig"}).

### Meta-analysis of ESWT vs. physical therapy

A total of two studies ([@b18-etm-0-0-7897],[@b22-etm-0-0-7897]) involving 75 patients reported on the pain score around 5 weeks following completion of therapy. The statistical heterogeneity between the studies was considerable according to the random-effects model (P=0.13, I^2^=56%). The VAS scores of the ESTW patients were significantly lower than of those with physical therapy for \~1 month (MD=−1.98, 95% CI: −2.93 to −1.03, P\<0.00001; [Fig. 7](#f7-etm-0-0-7897){ref-type="fig"}).

The ROM of knees around 5 weeks following completion of therapy was reported by two studies ([@b18-etm-0-0-7897],[@b23-etm-0-0-7897]) including 95 patients. The statistical heterogeneity between the studies was acceptable using a random-effects model (P=0.20, I^2^=39%). The increase in the ROM scores during the treatment in the ESWT group was significantly higher than that in the physical therapy group (MD=11.69, 95% CI: 6.40--16.98, P\<0.00001; [Fig. 8](#f8-etm-0-0-7897){ref-type="fig"}).

Furthermore, two studies ([@b22-etm-0-0-7897],[@b23-etm-0-0-7897]) comprising 60 patients described the WOMAC around 4 weeks following completion of therapy. The statistical heterogeneity between the studies was low according to analysis with the random-effects model (P=0.77, I^2^=0%). The WOMAC in the ESWT patients exhibited a greater decrease than that in the physical therapy patients after treatment (MD=−15.38, 95% CI: −18.87 to −11.89, P\<0.00001; [Fig. 9](#f9-etm-0-0-7897){ref-type="fig"}).

Discussion
==========

To the best of our knowledge, the present study was the first meta-analysis to investigate the efficacy and safety of ESWT as compared to physical therapy or placebo for the treatment of KOA. A series of RCTs on shockwave therapy has been performed for OA. In the ESWT group vs. placebo group analysis, the outcome indicators included were VAS, ROM and LI. Concerning pain control, one of the studies ([@b15-etm-0-0-7897]) indicated that shockwaves were not different from placebo in relieving severe pain for KOA. However, the combined analysis indicated that the shockwave group was significantly better than the placebo group, which was consistent with the individual studies. Furthermore, when the four studies were analyzed simultaneously, the heterogeneity was high (P=0.06, I^2^=59%). When the fourth study ([@b15-etm-0-0-7897]) was removed, the heterogeneity became reliable (P=0.33, I^2^=9%). Thus, it may be concluded that the heterogeneity of outcome indicators in this group originates from the last study ([@b15-etm-0-0-7897]). In addition, Imamura *et al* ([@b15-etm-0-0-7897]) used radial ESWT, which differs from shockwave equipment used in the other research studies. Furthermore, the patients selected were females and the pain was generally severe. The VAS score reached 7 points prior to the treatment whilst other studies reached around 5 points and this may have been the source of heterogeneity. Two studies ([@b18-etm-0-0-7897],[@b20-etm-0-0-7897]) assessed ROM and LI. Of note, the comprehensive analysis demonstrated that the patients in the shockwave group had a significantly greater ROM than the placebo group after treatment, and also, the LI was significantly reduced with acceptable heterogeneity, and hence, the result was reliable. However, the limited number of studies included in the present meta-analysis weakened the strength of the results regarding certain outcome measures such as ROM which only used 2 datasets, thereby necessitating the substantiation of the future results by a large number of RCTs.

In the ESWT group vs. physical therapy group analysis, the outcome indicators included the VAS, ROM and WOMAC scores. In terms of pain relief, the shockwave was significantly superior to physical exercise, albeit the heterogeneity in the two groups was slightly high (P=0.13, I^2^=56%). Thus, the reliability of the results was limited and hence, domestic studies from China were screened, revealing that the pain relief effect of ESWT was better than that of pure physical exercise therapy ([@b3-etm-0-0-7897]). Therefore, the small sample size may be the cause of heterogeneity. Furthermore, there is a similar meta-analysis ([@b7-etm-0-0-7897]), which produced similar results, with future clinical studies likely to confirm the results of the present study. Of note, in the ESWT group, the ROM ([@b18-etm-0-0-7897],[@b23-etm-0-0-7897]) and WOMAC ([@b22-etm-0-0-7897],[@b23-etm-0-0-7897]) score were significantly better than those in the physical therapy group and no obvious heterogeneity was detected in the two groups in the present study.

Of note, the present meta-analysis has several limitations. First, the number of relevant RCTs on the treatment of osteoarthritis was relatively low and the quality of the domestic studies was unreliable. Also, only studies published in English language were included, and hence, relevant studies published in other languages may have been missed. Furthermore, only seven studies were included and the sample size of each study was small, which limited the statistical power of the present meta-analysis. In addition, due to the limitation of the number of included studies, the therapeutic effects of the shockwaves of different energies were not analyzed, and all were combined into one shockwave group, which may have led to deviations of the results. Furthermore, the severity of OA prior to treatment may have also led to high heterogeneity and affected the reliability of the results. Finally, due to the limited literature, it was not possible to evaluate publication bias or to analyze functional outcomes e.g. post-operative quadriceps strength measures and the treatment costs due to insufficient data. Therefore, high-quality and large-scale clinical trials and systemic reviews are essential to confirm these results in the future.

In conclusion, in the treatment of KOA, the effects of ESWT are superior to those of placebo and physical therapy. Besides the pain relief, ESWT increases the mobility of the knee joint and may reduce the LI and WOMAC score. The evidence supported the selection of shock wave for the treatment of KOA patients; however, due to the lack of relevant high-quality literature and similar previous meta-analyses, and the fact that certain studies did not utilize a blinding method, the results require to be further substantiated.
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###### 

Baseline characteristics of the studies included.

  A, ESWT vs. placebo                                                                                                                                                                                                                             
  ---------------------------------- ------------------------------------- ------------------------------------------ ---------------------------------------- ------------------------------------------- -------------------------------------- -----------------------
  Chen et al, 2014                   Bilateral knees                       30                                         30                                       1\. ROM                                     After 8 weeks (physical and placebo)   ([@b18-etm-0-0-7897])
                                                                                                                                                               2\. VAS (after walking or standing 5 min)   After 6 weeks (ESWT)                   
                                                                                                                                                               3\. Li                                                                             
  Cho et al, 2016                    Bilateral knees or unilateral knees     9                                          9                                                                                  After 1 week                           ([@b19-etm-0-0-7897])
  Elerian et al, 2016                Bilateral knees                       20                                         20                                       VAS                                         WOMAC                                  ([@b20-etm-0-0-7897])
                                                                                                                                                               ROM                                         After 8 weeks                          
  Imamura et al, 2017                Bilateral knees                       52                                         53                                       VAS                                         After 12 weeks                         ([@b15-etm-0-0-7897])
                                                                                                                                                               WOMAC                                                                              
  Zhao et al, 2013                   Unilateral OA or more painful side    30                                         31                                       1\. VAS                                     After 4 weeks and 12 weeks             ([@b21-etm-0-0-7897])
                                                                                                                                                               2\. LI                                                                             
                                                                                                                                                               3\. WOMAC                                                                          
                                                                                                                                                                                                                                                  
  **B, ESWT vs. physical therapy**                                                                                                                                                                                                                
                                                                                                                                                                                                                                                  
  **First author, year**             **OA joints included**                **Size of intervention group (ESWT), n**   **Size of control group (placebo), n**   **Outcomes**                                **Follow-up**                          **(Refs.)**
                                                                                                                                                                                                                                                  
  Chen et al, 2014                   Bilateral knees                       30                                         30                                       1\. ROM                                     After 8 weeks (physical and placebo)   ([@b18-etm-0-0-7897])
                                                                                                                                                               2\. VAS                                     After 6 weeks (ESWT)                   
                                                                                                                                                               3\. LI                                                                             
  Lee et al, 2017                    Bilateral knees                       10                                         10                                       1\. VAS                                     After 4 weeks                          ([@b22-etm-0-0-7897])
                                                                                                                                                               2\. WOMAC                                                                          
  Lizis et al, 2017                  Unilateral knee                       20                                         20                                       ROM                                         After 5 weeks                          ([@b23-etm-0-0-7897])
                                                                                                                                                               WOMAC                                                                              

OA, osteoarthritis; ESWT, extracorporeal shockwave therapy; ROM, range of motion; VAS, visual analogue scale; LI, Lequesne index; WOMAC, Western Ontario and McMaster Universities osteoarthritis index.
